CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
CURE now has the right to manufacture pharmaceuticals based on both — those based on the...
Read MoreSelect Page
Posted by Invest In Weed | Mar 12, 2019
CURE now has the right to manufacture pharmaceuticals based on both — those based on the...
Read MorePosted by Invest In Weed | Mar 12, 2019
Corbus Pharmaceuticals also provided an update on its corporate progress, clinical status and...
Read MoreGet stock alerts, news & related alerts straight to your inbox!